MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$2,581,000
Net Income
-$145,000
Net Profit Margin
-5.62%
EPS
-$0.02
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-04-30
2026-01-31
2025-10-31
2025-07-31
Revenues (includes sales to related parties of approximately 30,000, 43,000, 30,000, and 75,000, respectively)
2,581,000
1,446,000
1,516,500*
1,306,000
Cost of revenues
526,000
281,000
205,000*
228,000
Gross profit
2,055,000
1,165,000
1,311,500*
1,078,000
General and administrative expenses
2,567,000
2,043,000
1,606,500*
3,149,000
Loss from operations
-512,000
-878,000
-295,000*
-2,071,000
Gain on sale of exotropin interests
-390,000
-
-
-
Interest expense
11,000
10,000
32,000*
23,000
Change in obligation to repurchase shares
-
-
500*
-
Inducement expense to convert notes in payable
-
-
34,000*
-
Change in obligation to repurchase shares
17,000
-19,000
-
0
Other income
5,000
17,000
35,000*
22,000
Net loss
-145,000
-852,000
-326,500
-2,072,000
Basic EPS
-0.02
-0.12
-0.05
-0.32
Diluted EPS
-0.02
-0.12
-0.05
-0.32
Basic Average Shares
7,757,469
7,021,599
6,479,599
6,405,443
Diluted Average Shares
7,757,469
7,021,599
6,479,599
6,405,443
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Net loss
-$145,000
(89.58%↑ Y/Y)
Gain on sale of
exotropin interests
-$390,000
Revenues (includes sales
to related parties...
$2,581,000
(124.63%↑ Y/Y)
Other income
$5,000
(-79.17%↓ Y/Y)
Loss from operations
-$512,000
(63.27%↑ Y/Y)
Gross profit
$2,055,000
(130.12%↑ Y/Y)
Change in obligation to
repurchase shares
$17,000
Interest expense
$11,000
(-47.62%↓ Y/Y)
Cost of revenues
$526,000
(105.47%↑ Y/Y)
General and
administrative expenses
$2,567,000
(12.24%↑ Y/Y)
Buy us a coffee
Zeo ScientifiX, Inc. (ZEOX)
Zeo ScientifiX, Inc. (ZEOX)